Patient preferences for advanced therapies in ulcerative colitis using conjoint analysis
Patient preferences for the route/frequency of administration, as well as other drug profiles, change with disease severity but demonstrate substantial interindividual variability. Therefore, shared decision-making is important to incorporate patients' perspectives into the selection of advanced therapies.
Authors
- Yoshiko Ikawa (ORCID: https://orcid.org/0000-0002-6521-6617)
- Hirono Ishikawa (ORCID: https://orcid.org/0000-0003-1458-6957)
- Taku Kobayashi (ORCID: https://orcid.org/0000-0002-2073-4234)
- Naomi Mizuno (ORCID: https://orcid.org/0000-0002-1326-9792)
- Noriko Sato (ORCID: https://orcid.org/0000-0003-2660-0808)
- Naruyasu Komorita
- Y Kawaguchi
Institutions
- Kitasato Institute Hospital (JP)
- Mitsubishi Tanabe Pharma Corporation
- Kitasato University (JP)
- Teikyo University (JP)
Publication Details
- Journal
- Intestinal Research
- Published
- 2024-10-14
- DOI
- https://doi.org/10.5217/ir.2024.00101
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Mitsubishi Tanabe Pharma Corporation